Cited by 109Metabolism and Genetic DisordersLysosomal Storage Disorders ResearchGenomics and Rare Diseases

Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation

Open access
Kemper, Alex R., Brosco, Jeffrey, Comeau, Anne Marie, Green, Nancy S., Grosse, Scott D., Jones, Elizabeth, Kwon, Jennifer M., Lam, Wendy K.K. +3 more·2017·Genetics in Medicine

Abstract

The secretary of the US Department of Health and Human Services in February 2016 recommended that X-linked adrenoleukodystrophy (X-ALD) be added to the recommended uniform screening panel for state newborn screening programs. This decision was informed by data presented on the accuracy of screening from New York, the only state that currently offers X-ALD newborn screening, and published and unpublished data showing health benefits of earlier treatment (hematopoietic stem cell transplantation and adrenal hormone replacement therapy) for the childhood cerebral form of X-ALD. X-ALD newborn screening also identifies individuals with later-onset disease, but poor genotype-phenotype correlation makes predicting health outcomes difficult and might increase the risk of unnecessary treatment. Few data are available regarding the harms of screening and presymptomatic identification. Significant challenges exist for implementing comprehensive X-ALD newborn screening, including incorporation of the test, coordinating follow-up diagnostic and treatment care, and coordination of extended family testing after case identification.Genet Med 19 1, 121-126.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/gim.2016.68

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The early detection of the characteristic biochemical abnormalities associated with ALD and AMN has proven to be reliable to detect affected subjects but also poses new clinical ethical issues.

    “The early detection of the characteristic biochemical abnormalities associated with ALD and AMN has proven to be reliable to detect affected subjects but also poses new clinical ethical issues (52).”

    From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [52]

    The Conclusions (page unavailable) say New York data suggest X-ALD can be reliably identified through newborn screening, and the Potential harms section describes concerns about unwanted carrier information, anxiety, false positives, and overdiagnosis. The paper does not say biochemical screening can identify who will develop AMN; it notes poor prediction of disease course. Thus the claim overstates both the certainty of detection and its specificity for AMN. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • From that time onward, some countries have implemented their neonatal screening program with ALD screening.

    “From that time onward, some countries have implemented their neonatal screening program with ALD screening (52).”

    From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [52]

    The Newborn screening program implementation section reports that New York was screening newborns for X-ALD. It does not establish that multiple countries had implemented ALD screening; the other jurisdictions it names are US states that had not yet begun screening. No page number is available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [3]Ruiz M Coll MJ Pàmpols T Girós M X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds Am J Med Genet 1998 76 424 427 9556303
  2. [15]Mitchell R Nivison-Smith I Anazodo A Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry Pediatr Transplant 2013 17 582 588 23802616
  3. [29]Miller WP Rothman SM Nascene D Outcomes after allogeneic hematopoietic stem cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report Blood 2010 116 1971 1978 21586746

Cited by

Sorted by citations

Authors
Kemper, A. R., Brosco, J., Comeau, A. M., Green, N. S., Grosse, S. D., Jones, E., Kwon, J. M., Lam, W. K. K., Ojodu, J., Prosser, L. A., & Tanksley, S.
Affiliations
  • Duke University (US)
  • University of Miami (US)
  • University of Massachusetts Chan Medical School (US)
  • Columbia University Irving Medical Center (US)
  • Centers for Disease Control and Prevention (US)
  • Association of Public Health Laboratories (US)
  • University of Rochester Medicine (US)
  • University of Michigan (US)
  • Texas Department of State Health Services (US)
Corresponding author
Kemper, Alex R.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2017-01
Volume
19
Issue
1
Pages
121-126
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2466367464
Cited by
109
References
34
Citations by year
2026: 11 · 2025: 12 · 2024: 7 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 12 · 2019: 12 · 2018: 13 · 2017: 5 · 2016: 1
FWCI
10.10
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
  • U.S. Department of Health and Human Services
  • Association of Public Health Laboratories
  • National Institutes of Health (CC999999)
  • Centers for Disease Control and Prevention
  • Health Resources and Services Administration (HHSH250201400007C)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
X-linked adrenoleukodystrophy, newborn screening, screening accuracy, childhood cerebral adrenoleukodystrophy, hematopoietic stem cell transplantation, genotype-phenotype correlation, New York
MeSH terms
ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Female, Humans, Infant, Newborn, Male, Mutation, New York, Phenotype, United States, United States Dept. of Health and Human Services, Neonatal Screening, Advisory Committees

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review